2025 ARIA Summit

Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease
July 16, 2025, 8:30 a.m. – 4:00 p.m.
Chicago, Illinois


American Heart Association's ARIA Summit: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease

Overview

The American Heart Association convened the ARIA Summit: Cardiovascular and Stroke Considerations for β-Amyloid Immunotherapy in Alzheimer Disease on July 16, 2025 in Chicago, Illinois.

This one-day, invite only, in-person event brought together over 75 experts from diverse fields – including neurology, emergency medicine, cardiology, nursing, risk communications, ethics, and more – to share insights on ARIA and explore considerations for issues related to the use of amyloid plaque lowering monoclonal antibodies and their side effects.

The Summit included plenary sessions on ARIA and considerations for improving systems of care, followed by breakout workshops where work groups will develop considerations for key issues related to the use of β-amyloid immunotherapy. Insights from the Summit will inform the development of an ARIA Summit Special Report, which will be made available here.

Summit Goals

  • Share the latest research, challenges and insights on ARIA.
  • Identify clinical and systems of care considerations for implementing β-amyloid therapies in patients with cardiovascular or stroke risk.
  • Surface future research and data collection needs.

Materials

Co-Chairs

Steven Greenberg, MD, PhD

Steven Greenberg, MD, PhD

Co-Chair, ARIA Summit
Harvard Medical School
Massachusetts General Hospital
Constantino Iadecola, MD

Costantino Iadecola, MD

Co-Chair, ARIA Summit
Weill Cornell Medicine

Speakers

Cynthia Carlsson, MD, MS

Cynthia Carlsson, MD, MS

University of Wisconsin Department of Medicine

Col. Joellen de Berg, RN, BSN, MA

Col. Joellen de Berg, RN, BSN, MA

Col. Oak Deberg, PhD

Col. Oak Deberg, PhD

The University of Texas at San Antonio
David Knopman, MD

David Knopman, MD

Mayo Clinic
Sharon J. Sha, MD, MS

Sharon J. Sha, MD, MS

Stanford University
Maggie Tubiello, MBA, MSN, RN

Maggie Tubiello, MBA, MSN, RN

Penn Medicine

Planning Committee

A multidisciplinary planning committee of clinicians, researchers, and organization leaders has been convened to inform the event agenda and support the development of the Summit Special Report.
Alessandro Biffi, MD

Alessandro Biffi, MD

Eli Lilly and Company
Sherry Chou, MD

Sherry Chou, MD

Northwestern Feinberg School of Medicine
Petrice Cogswell, MD, PhD

Petrice Cogswell, MD, PhD

Mayo Clinic
Mitchell Elkind, MD

Mitch Elkind, MD

American Heart Association
William Hicks, MD

William Hicks, MD

Ohio Health
Deborah Levine, MD, PhD

Deborah Levine, MD,  PHD

Michigan Medicine
Richard Lipton, MD

Richard Lipton, MD

Albert Einstein College of Medicine

Lauren Massimo, PhD, CRNP

Lauren Massimo, PhD, CRNP

Penn Medicine

Sudha Seshadri, MD, DM

Sudha Seshadri, MD, DM

University of Texas Health San Antonio

Heather Snyder, MD

Heather Snyder, PhD

Alzheimer's Association

Kristine Yaffe, MD

Kristine Yaffe, MD

University of California, San Francisco Medical Center

Kori Zachrison, MD, MSC

Kori Zachrison, MD, MSc

Harvard Medical School
Massachusetts General Hospital

Eli Lilly & Company logo


Lilly is a supporter of the American Heart Association’s ARIA Summit.